Back
Evolent Health 10K Form
Sell
9
EVH
Evolent Health
Last Price:
11.27
Seasonality Move:
2.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive EVH News And Ratings
See the #1 stock for the next 7 days that we like better than EVH
EVH Financial Statistics
Sales & Book Value
Annual Sales: | $1.96B |
---|---|
Cash Flow: | $12.38M |
Price / Cash Flow: | 11.74 |
Annual Sales: | $9.03 |
Price / Book: | 1.25 |
Profitability
EPS (TTM): | -0.91000 |
---|---|
Net Income (TTM): | $-72.23M |
Gross Margin: | $460.47M |
Return on Equity: | -6.81% |
Return on Assets: | -2.79% |
Evolent Health Earnings Forecast
Key Evolent Health Financial Ratios
- The Gross Profit Margin over the past 11 years for EVH is 23.45%.
- The Selling, General & Administrative Expenses for EVH have been equal to 18.23% of Gross Profit Margin.
- The Interest Expense is -47.95% of Operating Income.
- The Net Earning history of EVH is -5.76% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Evolent Health Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Technology |
Sector: | Health Care |
Current Symbol: | EVH |
CUSIP: | 30050B |
Website: | evolenthealth.com |
Debt
Debt-to-Equity Ratio: | 0.58 |
---|---|
Current Ratio: | 1.04 |
Quick Ratio: | 0.96 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 11.64 |
EVH Technical Analysis vs Fundamental Analysis
Sell
9
Evolent Health (EVH)
is a Sell
Is Evolent Health a Buy or a Sell?
-
Evolent Health stock is rated a Sell
The current Evolent Health [EVH] share price is $11.25. The Score for EVH is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.